Working to Eradicate Gynecologic Cancers

Paula M. Fracasso, MD, PhD

Professor of Medicine
University of Virginia
Medicine
University of Virginia
PO Box 800716
Charlottesville, VA
USA 22908

Papers:
51 A Phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: a Gynecologic Oncology Group study